Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

NCT05361915 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

100

Enrollment

INDUSTRY

Sponsor class

Stopped Sorrento Therapeutics filed for chapter 11 bankruptcy.

Conditions

Prostate Cancer
Prostate Cancer Metastatic

Interventions

DRUG: Abivertinib
DRUG: Abiraterone

Sponsor

Sorrento Therapeutics, Inc.